Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ZYNE
Tag: NASDAQ:ZYNE
Zynerba Initiates Phase II INSPIRE Trial Of Zygel
ME Staff
-
May 31, 2019
0
Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002
ME Staff
-
December 19, 2018
0
Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...
ME Staff
-
May 31, 2018
0
Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...
ME Staff
-
March 23, 2018
0
Analyst Activity – Ladenburg Thalmann Financial Services Initiates Coverage On Zynerba...
ME Staff
-
January 29, 2018
0
Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...
ME Staff
-
January 3, 2018
0
Biotech Movers: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and PTC Therapeutics, Inc. (NASDAQ:PTCT)
-
September 29, 2017
0
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Reports Third Quarter 2016...
ME Staff
-
November 14, 2016
0
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Announces Initiation of STAR...
ME Staff
-
November 2, 2016
0
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K
ME Staff
-
October 18, 2016
0
